For two decades, that has been the mantra of heart doctors and their patients: Lower LDL, or "bad" cholesterol, reduces the risk of heart attack and stroke and prolongs life. But a controversial study ...

This predominance of small, dense LDL particles has been termed the atherogenic lipoprotein profile (ALP) and is linked to several metabolic issues that help explain its atherogenicity. [5] This trait ...

High cholesterol and age are two significant risk factors for heart disease, which is the leading cause of death in the ...

On the surface, this looked like an unusual case of heart attack. This 40-year-old patient of mine had a very desirable LDL (low-density lipoprotein or bad cholesterol) of 55 mg/dL. As cardiologists, ...

Inclisiran inhibits hepatic synthesis of proprotein convertase subtilisin–kexin type 9. Previous studies suggest that inclisiran might provide sustained reductions in low-density lipoprotein (LDL) ...

A 47-year-old premenopausal female, with no past history of hyperlipidemia, hypertension, or diabetes was admitted with an evolving inferior myocardial infarction complicated by ventricular ...